Isothermal and nonisothermal decomposition of thymopentin and its analogs in aqueous solution
- PMID: 9833991
- DOI: 10.1023/a:1011952511091
Isothermal and nonisothermal decomposition of thymopentin and its analogs in aqueous solution
Abstract
Purpose: The degradation kinetics of thymopentin (RKDVY) and its analogs (RKDVW and RPDVY) in aqueous solution was studied by isothermal and nonisothermal methods.
Methods: The isothermal decomposition of thymopentin and its analogs was investigated as a function of pH (2-10), temperature (37, 57, and 80 degrees C) and ionic strength (micro = 0.02 to 1). Nonisothermal decomposition studies were performed using a linear temperature programmer. The temperature increasing rate was set to 0.25 degrees C per hour and the temperature interval varied from 40 to 88 degrees C.
Results: The decomposition of thymopentin and its analogs followed first order kinetics. The dependence of the rate constant on temperature followed a linear Arrhenius plot. This indicated that the degradation mechanism of thymopentin and its analogs might be the same within the temperature range studied. The energies of activation were found to be in close agreement for the isothermal and nonisothermal studies, suggesting that the nonisothermal studies may save considerable amount of time in the early stages of drug development. The logK-pH profile of thymopentin suggests that maximum stability is achieved in the pH range of 6-8.
Conclusions: These results indicate that the nonisothermal methodology provides an attractive alternative to isothermal methods, as it requires a much lower amount of both material and time, to determine the peptide stability and to estimate the shelf-life for peptide pharmaceutical preparations.
Similar articles
-
Data analysis of kinetic modelling used in drug stability studies: isothermal versus nonisothermal assays.Pharm Res. 2006 Nov;23(11):2595-602. doi: 10.1007/s11095-006-9096-0. Epub 2006 Sep 13. Pharm Res. 2006. PMID: 16969699
-
Isothermal and nonisothermal decomposition of famotidine in aqueous solution.Pharm Res. 1995 Apr;12(4):599-604. doi: 10.1023/a:1016222501079. Pharm Res. 1995. PMID: 7596998
-
Evaluation of cholecystokinin (CCK-8) peptide thermal stability for use as radiopharmaceutical by means isothermal and nonisothermal approaches.Drug Dev Ind Pharm. 2006 Sep;32(8):947-53. doi: 10.1080/03639040600599855. Drug Dev Ind Pharm. 2006. PMID: 16954107
-
Nonisothermal stability tests of famotidine and nizatidine.Farmaco. 2002 Sep;57(9):729-35. doi: 10.1016/s0014-827x(02)01266-1. Farmaco. 2002. PMID: 12385523
-
An Overview of Parameters Controlling the Decomposition and Degradation of Ti-Based Mn+1AXn Phases.Materials (Basel). 2019 Feb 4;12(3):473. doi: 10.3390/ma12030473. Materials (Basel). 2019. PMID: 30720713 Free PMC article. Review.
Cited by
-
Data analysis of kinetic modelling used in drug stability studies: isothermal versus nonisothermal assays.Pharm Res. 2006 Nov;23(11):2595-602. doi: 10.1007/s11095-006-9096-0. Epub 2006 Sep 13. Pharm Res. 2006. PMID: 16969699
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources